Brief: Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial And Operating Results And Provides Business Update
16/08/2021 21:49
Aug 16 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.54
* AS OF JUNE 30, 2021, HAD CASH AND CASH EQUIVALENTS OF
$56.7
MILLION
* EXPECT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO
FUND OUR
OPERATIONS INTO Q1 OF 2023.
Source text for Eikon: ID:nGNX7GDg5z
Further company coverage: ELOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eloxx Pharmaceuticals
See all newsNASDAQ RESUMED AT 02:24 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM
Brief: Eloxx Pharmaceuticals Provides ELX-02 And ZKN-013 Program Updates
Brief: Eloxx Pharmaceuticals Confirms That Alport Syndrome Patients Treated With Elx-02 In Phase 2 Study Had Improvement
Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome